Leinonen JS - Search Results

1

What is a disease? Perspectives of the public, health professionals and legislators.

Tikkinen KA, Leinonen JS, Guyatt GH, Ebrahim S, Järvinen TL. Tikkinen KA, et al. Among authors: leinonen js. BMJ Open. 2012 Dec 2;2(6):e001632. doi: 10.1136/bmjopen-2012-001632. Print 2012. BMJ Open. 2012. PMID: 23204142 Free PMC article.

2

Public, health professional and legislator perspectives on the concept of psychiatric disease: a population-based survey.

Tikkinen KAO, Rutanen J, Frances A, Perry BL, Dennis BB, Agarwal A, Maqbool A, Ebrahim S, Leinonen JS, Järvinen TLN, Guyatt GH. Tikkinen KAO, et al. Among authors: leinonen js. BMJ Open. 2019 Jun 4;9(6):e024265. doi: 10.1136/bmjopen-2018-024265. BMJ Open. 2019. PMID: 31167856 Free PMC article.

3

Infectious anxiety disorder.

Cassels A, Leinonen J, Järvinen TL. Cassels A, et al. CMAJ. 2014 Jun 10;186(9):720. doi: 10.1503/cmaj.140352. Epub 2014 May 20. CMAJ. 2014. PMID: 24847139 Free PMC article. Review. No abstract available.

4

Immunohistochemical demonstration of carbonic anhydrase isoenzyme VI (CA VI) expression in rat lower airways and lung.

Leinonen JS, Saari KA, Seppänen JM, Myllylä HM, Rajaniemi HJ. Leinonen JS, et al. J Histochem Cytochem. 2004 Aug;52(8):1107-12. doi: 10.1369/jhc.4A6282.2004. J Histochem Cytochem. 2004. PMID: 15258187

5

Assay of antioxidant capacity of human plasma and CSF in aging and disease.

Alho H, Leinonen JS, Erhola M, Lönnrot K, Aejmelaeus R. Alho H, et al. Among authors: leinonen js. Restor Neurol Neurosci. 1998 Jun;12(2-3):159-65. Restor Neurol Neurosci. 1998. PMID: 12671311

6

Low plasma antioxidant activity is associated with high lesion volume and neurological impairment in stroke.

Leinonen JS, Ahonen JP, Lönnrot K, Jehkonen M, Dastidar P, Molnár G, Alho H. Leinonen JS, et al. Stroke. 2000 Jan;31(1):33-9. doi: 10.1161/01.str.31.1.33. Stroke. 2000. PMID: 10625712

7

Association between M/L55-polymorphism of paraoxonase enzyme and oxidative DNA damage in patients with type 2 diabetes mellitus and in control subjects.

Malin R, Rantalaiho V, Huang XH, Wirta O, Pasternack A, Leinonen JS, Alho H, Jokela H, Koivula T, Tanaka T, Okada K, Ochi H, Toyokuni S, Lehtimäki T. Malin R, et al. Among authors: leinonen js. Hum Genet. 1999 Jul-Aug;105(1-2):179-80. doi: 10.1007/s004399900074. Hum Genet. 1999. PMID: 10480377

8

Unaltered antioxidant activity of plasma in subjects at increased risk for IDDM.

Leinonen JS, Alho H, Harmoinen A, Lehtimäki T, Knip M. Leinonen JS, et al. Free Radic Res. 1998 Aug;29(2):159-64. doi: 10.1080/10715769800300181. Free Radic Res. 1998. PMID: 9790518

9

The level of autoantibodies against oxidized LDL is not associated with the presence of coronary heart disease or diabetic kidney disease in patients with non-insulin-dependent diabetes mellitus.

Leinonen JS, Rantalaiho V, Laippala P, Wirta O, Pasternack A, Alho H, Jaakkola O, Ylä-Herttuala S, Koivula T, Lehtimäki T. Leinonen JS, et al. Free Radic Res. 1998 Aug;29(2):137-41. Free Radic Res. 1998. PMID: 9790515

10

Susceptibility of LDL to oxidation is not associated with the presence of coronary heart disease or renal dysfunction in NIDDM patients.

Leinonen JS, Rantalaiho V, Solakivi T, Koivula T, Wirta O, Pasternack A, Alho H, Lehtimäki T. Leinonen JS, et al. Clin Chim Acta. 1998 Jul 28;275(2):163-74. doi: 10.1016/s0009-8981(98)00083-7. Clin Chim Acta. 1998. PMID: 9721074 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters